Perbedaan Brigit Biofarmaka Teknologi Tbk. dan Phapros Tbk.: Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp254 (kapitalisasi pasar 172,82 M, volume 24 jam 592,2 rb), sedangkan Phapros Tbk. diperdagangkan di Rp254 (kapitalisasi pasar 220,08 M, volume 24 jam 204,7 rb). Perbedaan utamanya: Phapros Tbk. lebih besar dari sisi kapitalisasi pasar, dan Brigit Biofarmaka Teknologi Tbk. lebih aktif diperdagangkan (592,2 rb vs 204,7 rb). Mana yang lebih baik tergantung tujuan investasimu.
| OBAT | PEHA | |
|---|---|---|
Kapitalisasi Pasar | 172,82 M | 220,08 M |
Volume | 592,2 rb | 204,7 rb |
Lot | 5,92 rb | 2,05 rb |
Perputaran | 147,05 jt | 52,61 jt |
Harga Rata-rata | 248,31 | 256,99 |
Nilai Transaksi | 147,05 jt | 52,61 jt |
Harga Ekuilibrium Indikatif | 254 | — |
Volume Ekuilibrium Indikatif | 10 | — |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →PT Phapros Tbk was established under the name of N.V. Pharmaceutical Processing Industries, in short N.V. Phapros, based on Notarial Deed No 54 of Tan A Sioe dated 21 June 1954, which later became PT Pharmaceutical Processing Industries, in short PT Phapros based on Notarial Deed No.43 of E. Pondaag, replacing R.M. Soerojo, dated 5 September 1995, which finally became PT Phapros based on Notarial Deed No. 48 of Prof. Dr. Liliana Tedjosaputro, S.H., M.H., MM., dated 12 April 2006. The Company’s immediate and ultimate parent entity is PT Rajawali Nusantara Indonesia, incorporatedand domiciled in Indonesia.
Selengkapnya di halaman PEHA →